Inventor

Jeffrey S. Bland

Inventor
Fox Island, WA, US

Overview

36→
Patents
1997–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 36 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes45%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for9%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation9%
A62DChemical means for extinguishing fires or for combating or protecting against harmful chemical agents3%
C07CAcyclic or carbocyclic compounds3%
C07DHeterocyclic compounds3%
PatentTitleYear
10,220,068Phytonutrient compositions and methods to protect against radical mediated cellular and DNA damage20198,815,306'Methods and compositions for promoting bone and joint health'20148,557,306'Compositions that treat or inhibit pathological conditions associated with inflammatory response'20138,486,457'Compositions that treat or inhibit pathological conditions associated with inflammatory response'20138,475,850'Methods and compositions for heavy metal detoxification'20138,263,139'Protein kinase modulation by hops and Acacia products'20128,257,754'Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response'20128,241,674'Methods and compositions for heavy metal detoxification'20128,206,753'Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes'20128,193,201'Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines'20128,168,234'Compositions that treat or inhibit pathological conditions associated with inflammatory response'20128,142,819'Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response'20128,092,846'Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines'20127,919,125'Modulation of inflammation by hops fractions and derivatives'20117,914,831'Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines'20117,901,714'Treatment modalities for autoimmune diseases'20117,901,713'Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops'20117,820,206'Modulation of inflammation by hops fractions and derivatives'20107,815,944'Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity'20107,811,610'Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity'20107,807,203'Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity'20107,794,757'Modulation of inflammation by hops fractions and derivatives'20107,790,205'Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response'20107,736,677'Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment'20107,722,903'Modulation of inflammation by hops fractions and derivatives'20107,718,198'Treatment modalities for autoimmune diseases'20107,666,449'Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity'20107,431,948'Compositions that treat or inhibit pathological conditions associated with inflammatory response'20087,270,835'Compositions that treat or inhibit pathological conditions associated with inflammatory response'20076,602,517'Dietary supplements for treating inflammation-related diseases'20036,352,712'Dietary supplements for treating fatigue-related syndromes'20026,210,701'Medical food for treating inflammation-related diseases'20016,051,260'Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity'20005,922,704'Optimal nutritional supplement for men'19995,637,324'Medical food composition for metabolic detoxification'19975,629,023'Medical food composition for metabolic detoxification'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2019Based in Fox Island, WA, US· patent location history
1999Based in Gig Harbor, WA, US· patent location history
2007–2019Patents assigned to METAPROTEOMICS LLC (28)· patent assignee history
2012–2014Patents assigned to BLAND JEFFREY S (12)· patent assignee history
2012–2014Patents assigned to TRIPP MATTHEW L (12)· patent assignee history
2012–2013Patents assigned to BABISH JOHN G (9)· patent assignee history
2012–2014Patents assigned to KONDA VEERA (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
METAPROTEOMICS LLC282007–2019
BLAND JEFFREY Sself122012–2014
TRIPP MATTHEW L122012–2014
BABISH JOHN G92012–2013
KONDA VEERA52012–2014
Locations
LocationPatentsSpan
Fox Island, Washington, US351997–2019
Gig Harbor, Washington, US11999